Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer.
Hisada T, Kondo N, Wanifuchi-Endo Y, Osaga S, Fujita T, Asano T, Uemoto Y, Nishikawa S, Katagiri Y, Terada M, Kato A, Sugiura H, Okuda K, Kato H, Komura M, Morita S, Takahashi S, Toyama T. Hisada T, et al. Among authors: uemoto y. Sci Rep. 2022 Oct 3;12(1):16515. doi: 10.1038/s41598-022-20225-4. Sci Rep. 2022. PMID: 36192404 Free PMC article.
Low RAI2 expression is a marker of poor prognosis in breast cancer.
Nishikawa S, Uemoto Y, Kim TS, Hisada T, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Katagiri Y, Terada M, Kato A, Dong Y, Sugiura H, Okuda K, Kato H, Osaga S, Takahashi S, Toyama T. Nishikawa S, et al. Among authors: uemoto y. Breast Cancer Res Treat. 2021 May;187(1):81-93. doi: 10.1007/s10549-021-06176-w. Epub 2021 Mar 29. Breast Cancer Res Treat. 2021. PMID: 33782811
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study.
Terada M, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Uemoto Y, Akiko Kato, Yamanaka N, Sugiura H, Mita K, Wada A, Takahashi E, Saito K, Yoshioka R, Toyama T. Terada M, et al. Among authors: uemoto y. Breast Cancer Res Treat. 2022 Oct;195(3):311-323. doi: 10.1007/s10549-022-06693-2. Epub 2022 Aug 8. Breast Cancer Res Treat. 2022. PMID: 35941421 Free PMC article.
Low TINAGL1 expression is a marker for poor prognosis in breast cancer.
Kato A, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Uemoto Y, Terada M, Kato H, Komura M, Okuda K, Takahashi S, Toyama T. Kato A, et al. Among authors: uemoto y. J Cancer Res Clin Oncol. 2023 Jul;149(8):4771-4782. doi: 10.1007/s00432-022-04394-3. Epub 2022 Oct 14. J Cancer Res Clin Oncol. 2023. PMID: 36229542
[Primary breast diffuse large B-cell lymphoma in a male].
Tokuyama K, Uemoto Y, Kitagawa S, Ohashi H. Tokuyama K, et al. Among authors: uemoto y. Rinsho Ketsueki. 2017;58(5):455-457. doi: 10.11406/rinketsu.58.455. Rinsho Ketsueki. 2017. PMID: 28592759 Japanese.
124 results